The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Thanks deemule, JackDiamonds, I have been waiting to find out what the road map was for Daybreak ever since the deal. Nice to see the range of projects and goals spelled out in a presentation. A target of $8m cash flow (not profit) in 2.5 years, it's not going to change the world but based on the initial investment pretty damn good! No news does not mean nothing is happening, depending on the company of cause :D.
I used to do scalp 20% of my holding many times, 2019 but it was only 2-3k. 2020-2022 has been rubbish for scalping. What we have seen is traders seeing better opportunities. For instance I sold a bit a few months back, because other shares I feel confident in looked like they are ready for a rise. By chance they did and I sold only to top back up in Faron a few times over the last month. The SP has been left hanging, 9 shares traded today says it all. For me I like the fact they are pushing on hard with multiple trials. As they should with patents in place, the clock is ticking. So it is the usual trading dilemma, do nothing and wait, or cut losses. Down 31% which is a bit sad compared to those 270% days. Hope this will be green soon, but not too soon I want another top up, lol.
There is an updated report 8.8.2022 on their investors website but its not in English. The usual time scale roadmaps, progress, some strategy talk. looks busy Q3 Q4 2022 though.
https://www.faron.com/investors
It's nothing like having a Van Gogh, if that was the case the SP would reflect the asset in the first place. The market values Victory as bugger all. That is the whole point of Reabold, picking up projects that are undervalued by the market. SP has been suppressed by the sealed bid. No Idea if anyone bought after the share event, but they must be thinking what is this company doing? Certainly a risk I am happy to take, but not topping up. Real, sold for a song, or a blag.
To be fair I was in NCYT from Feb 2020, they did not cheer long or more than most shareholders, came late into the game, and vanished after taking profit. Now that one had some delusional rampers ... all the way down again :D.
Have to admit I have started to wake up at 6:30 on work days again, this SP shift is not going to help matters :D. Still we have been here many times. Hope we all get rewarded for once, still under 50% so not close to being green on this one ...yet!
I think its at a very fair price for what is on the table. Unfortunately hamstrung waiting for projects to be brought forward. Too many changes on site for the CPR. Official year end balance for fundamentals not showing yet.
If some of these change we are moving, feeling pretty optimistic here. I am just on the cusp of being in the green, it all depends on your buy in price and when I guess.
Terrible to watch, hopefully people sliced for profit on the way up and the dip down. Have to admit I will buy some once things settle down, and my other shares actually go up. I have too many with high potential and not completing, at least Novacyt was/is earning. They do need to invest in other areas post covid, which they said throughout the crisis, was a thing.
Hope it bounces back a bit for you, early days yet.
It may go up on the share magazine youtube/own website in the end. Fully expect a hash of previous interviews though, although it would be interesting if they waved 'The Deal' around. Problem is it's one thing to be invested with an undisclosed deal, quite another for someone fresh to pile in. It does make us look a bit sketchy on the surface. I think what rubs a bit is, a separate board of Directors have known for nearly 2 months how big the deal is. I would prefer volatility, even if the deal is way lower that expected. But the SP is where they want it imo so, suck it up :D.
A delay isn't a massive surprise, taking 3 months to fess up is pretty rubbish. At least we have a roadmap for WN.
From RNS
Fri, 27th May 2022; Full Year Results for the year ended 31 Dec 2021
'The Company's current financial position is strong and funding is in place for the key 2022 work programmes to drive what the Board expects to be a transformative value driving year ahead. '
What a difference a month makes. Ah well was not expecting the main site to do much this year, and they want more drill data from Site B. If they bungle the Victory flip ... its going to be messy for a while.
Back to waiting.